5-aminovaleric acid

5-aminovaleric acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 627 references associated with 5-aminovaleric acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 5-aminovaleric acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 5-aminovaleric acid

MeSH term MeSH ID Detail
Skin Neoplasms D012878 12 associated lipids
Catalepsy D002375 30 associated lipids
Hyperkinesis D006948 11 associated lipids
Huntington Disease D006816 4 associated lipids
Myoclonus D009207 3 associated lipids
Neoplasms, Second Primary D016609 4 associated lipids
Paget Disease, Extramammary D010145 1 associated lipids
Paget's Disease, Mammary D010144 1 associated lipids
Total 8

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 5-aminovaleric acid

Download all related citations
Per page 10 20 50 100 | Total 167
Authors Title Published Journal PubMed Link
Shin JH et al. Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid. 2016 Microb. Cell Fact. pmid:27717386
Rohles CM et al. Systems metabolic engineering of Corynebacterium glutamicum for the production of the carbon-5 platform chemicals 5-aminovalerate and glutarate. 2016 Microb. Cell Fact. pmid:27618862
Naffaa MM et al. Investigating the Role of Loop C Hydrophilic Residue 'T244' in the Binding Site of ρ1 GABAC Receptors via Site Mutation and Partial Agonism. 2016 PLoS ONE pmid:27244450
Liu P et al. Enzymatic production of 5-aminovalerate from L-lysine using L-lysine monooxygenase and 5-aminovaleramide amidohydrolase. 2014 Sci Rep pmid:25012259
Dhaher R et al. 5-aminovaleric acid suppresses the development of severe seizures in the methionine sulfoximine model of mesial temporal lobe epilepsy. 2014 Neurobiol. Dis. pmid:24632421
Chou HT et al. Functional characterization of the agtABCD and agtSR operons for 4-aminobutyrate and 5-aminovalerate uptake and regulation in Pseudomonas aeruginosa PAO1. 2014 Curr. Microbiol. pmid:23982201
Chirapu SR et al. Undesired versus designed enzymatic cleavage of linkers for liver targeting. 2014 Bioorg. Med. Chem. Lett. pmid:24461291
Bandari RP et al. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer. 2014 Nucl. Med. Biol. pmid:24508213
Adkins J et al. Engineering Escherichia coli for renewable production of the 5-carbon polyamide building-blocks 5-aminovalerate and glutarate. 2013 Biotechnol. Bioeng. pmid:23296991
Park SJ et al. Metabolic engineering of Escherichia coli for the production of 5-aminovalerate and glutarate as C5 platform chemicals. 2013 Metab. Eng. pmid:23246520